Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Effects of case- and population-based COVID-19 interventions in Taiwan

View ORCID ProfileTa-Chou Ng, Hao-Yuan Cheng, Hsiao-Han Chang, Cheng-Chieh Liu, Chih-Chi Yang, Shu-Wan Jian, Ding-Ping Liu, Ted Cohen, Hsien-Ho Lin
doi: https://doi.org/10.1101/2020.08.17.20176255
Ta-Chou Ng
1Institute of Epidemiology and Preventive Medicine, National Taiwan University College of Public Health, Taipei, Taiwan
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ta-Chou Ng
Hao-Yuan Cheng
2Epidemic Intelligence Center, Taiwan Centers for Disease Control, Taipei, Taiwan
3Department of Pediatrics, National Taiwan University Children’s Hospital, Taipei, Taiwan
MD, MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hsiao-Han Chang
4Institute of Bioinformatics and Structural Biology, National Tsing Hua University, Hsinchu City, Taipei
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hsienho{at}ntu.edu.tw
Cheng-Chieh Liu
1Institute of Epidemiology and Preventive Medicine, National Taiwan University College of Public Health, Taipei, Taiwan
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chih-Chi Yang
1Institute of Epidemiology and Preventive Medicine, National Taiwan University College of Public Health, Taipei, Taiwan
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shu-Wan Jian
2Epidemic Intelligence Center, Taiwan Centers for Disease Control, Taipei, Taiwan
DVM, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ding-Ping Liu
2Epidemic Intelligence Center, Taiwan Centers for Disease Control, Taipei, Taiwan
5National Taipei University of Nursing and Health Sciences, Taipei, Taiwan
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ted Cohen
6Department of Epidemiology of Microbial Diseases and the Public Health Modeling Unit, Yale School of Public Health, New Haven, Connecticut, USA
MD, DPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hsien-Ho Lin
1Institute of Epidemiology and Preventive Medicine, National Taiwan University College of Public Health, Taipei, Taiwan
7Global Health Program, National Taiwan University College of Public Health, Taipei, Taiwan
MD, ScD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Summary

In the first wave of the COVID-19 pandemic, broad usage of non-pharmaceutical interventions played a crucial role in controlling epidemics1–6. However, the substantial economic and societal costs of continuous use of border controls, travel restrictions, and physical distancing measures suggest that these measures may not be sustainable and that policymakers have to seek strategies to lift the restrictions. Taiwan was one of the few countries that demonstrated initial success in eliminating the COVID-19 outbreak without strict lockdown or school closure. To understand the key contributors to the successful control, we applied a stochastic branching model to empirical case data to evaluate and compare the effectiveness of more targeted case-based (including contact tracing and quarantine) and less targeted population-based interventions (including social distancing and face mask use) in Taiwan. We found that case-based interventions alone would not be sufficient to contain the epidemic, even in a setting where a highly efficient contact tracing program was in place. The voluntary population-based interventions have reduced the reproduction numbers by more than 60% and have likely played a critical role at the early stage of the outbreak. Our analysis of Taiwan’s success highlights that coordinated efforts from both the government and the citizens are indispensable in the fight against COVID-19 pandemic.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The study was funded by Taiwan Ministry of Science and Technology (MOST 109-2628-B-002-022-, and MOST 109-2628-B-002-031-). The funder of this study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

There is no need for IRB approval for this study.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The datasets generated and analyzed during the current study are available from the corresponding author on reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted August 19, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Effects of case- and population-based COVID-19 interventions in Taiwan
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Effects of case- and population-based COVID-19 interventions in Taiwan
Ta-Chou Ng, Hao-Yuan Cheng, Hsiao-Han Chang, Cheng-Chieh Liu, Chih-Chi Yang, Shu-Wan Jian, Ding-Ping Liu, Ted Cohen, Hsien-Ho Lin
medRxiv 2020.08.17.20176255; doi: https://doi.org/10.1101/2020.08.17.20176255
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Effects of case- and population-based COVID-19 interventions in Taiwan
Ta-Chou Ng, Hao-Yuan Cheng, Hsiao-Han Chang, Cheng-Chieh Liu, Chih-Chi Yang, Shu-Wan Jian, Ding-Ping Liu, Ted Cohen, Hsien-Ho Lin
medRxiv 2020.08.17.20176255; doi: https://doi.org/10.1101/2020.08.17.20176255

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)